FOXO1 and B-cell non-Hodgkin lymphoma: The antitumor effect of FOXO1 activation was also shown in different B cell lymphomas [13,16,17,18], moreover, for some of them we have provided evidence for a Goldilocks-like (too little is bad as well as too much) behavior of FOXOs [21,23].